Cloning of anti-HBsAg single-chain variable fragments from hybridoma cells for one-step ELISA

References

• World Health Organization. 2017. Available from: http://www.who.int/mediacentre/factsheets/fs204/en/, Hepatitis B, Fact sheet. Accessed June.
   Google Scholar
• Malik AH, Lee WM. Chronic hepatitis B virus infection: treatment strategies for the next millennium. Ann Intern Med. 2000;132:723–731.
   PubMed Web of Science ®Google Scholar
• Bose B, Chugh DA, Kala M et al. Characterization and molecular modeling of a highly stable anti-hepatitis B surface antigen scFv. Mole Immunol. 2003;40(9):617–631.
   PubMed Web of Science ®Google Scholar
• Scheiblauer H, El-Nageh M, Diaz S, et al. Performance evaluation of 70 hepatitis B virus (HBV) surface antigen (HBsAg) assays from around the world by a geographically diverse panel with an array of HBV genotypes and HBsAg subtypes. Vox Sang. 2010;98(3):403–414.
   PubMed Web of Science ®Google Scholar
• Huh HJ, Chae SL, Cha YJ. Comparison study with enzyme immunoassay and chemiluminescence immunoassay for hepatitis B virus surface antigen detection. Korean J Lab Med. 2007;27:355–359.
   PubMedGoogle Scholar
• Chen Y, Wu W, Li LJ, et al. Comparison of the results for three automated immunoassay systems in determining serum HBV markers. Clin Chim Acta. 2006;372:129–133.
   PubMed Web of Science ®Google Scholar
• Ismail N, Fish GE, Smith MB. Laboratory evaluation of a fully automated chemiluminescence immunoassay for rapid detection of HBsAg, antibodies to HBsAg, and antibodies to hepatitis C virüs. J Clin Microbiol. 2004;42:610–617.
   PubMed Web of Science ®Google Scholar
• Miedouge M, Legrand-Abravanel F, Lalanne C, et al. Laboratory evaluation of the UniCel DxI 800 analyser (Beckman Coulter) for detecting HBV and HCV serological markers. J Clin Virol. 2009;44:134–137.
   PubMed Web of Science ®Google Scholar
• Mühlbacher A, Weber B, Bürgisser P, et al. Multicenter study of a new fully automated HBsAg screening assay with enhanced sensitivity for the detection of HBV mutants. Med Microbiol Immunol. 2008;197(1):55–64.
   PubMed Web of Science ®Google Scholar
• Acar A, Kemahli S, Altunay H, et al. The significance of repeat testing in Turkish blood donors screened with HBV, HCV and HIV immunoassays and the importance of S/CO ratios in the interpretation of HCV/HIV screening test results and as a determinant for further confirmatory testing. Transfus Med. 2010;20(3):152–159.
   PubMed Web of Science ®Google Scholar
• Ziraba AK, Bwogi J, Namale A, et al. Sero-prevalence and risk factors for hepatitis B virus infection among health care workers in a tertiary hospital in Uganda. BMC Infect Dis. 2010;10:191.
   PubMed Web of Science ®Google Scholar
• Moerman B, Moons V, Sommer H, et al. Evaluation of sensitivity for wild type and mutant forms of hepatitis B surface antigen by four commercial HBsAg assays. Clin Lab. 2004;50:159–162.
   PubMedGoogle Scholar
• Weber B, Dengler T, Berger A, et al. Evaluation of two new automated assays for hepatitis B virus surface antigen (HBsAg) detection: IMMULITE HBsAg and IMMULITE 2000 HBsAg. J Clin Microbiol. 2003;41:135–143.
   PubMed Web of Science ®Google Scholar
• Lin YH, Wang Y, Loua A, et al. Evaluation of a new hepatitis B virus surface antigen rapid test with improved sensitivity. J Clin Microbiol. 2008;46(10):3319–3324.
   PubMed Web of Science ®Google Scholar
• Yücel F, Çırakoğlu B. MAbs against hepatitis B surface antigen. Hybridoma. 2000;19:501–502.
   PubMedGoogle Scholar
• Başalp A. Monoclonal antibodies against hepatitis B virus surface antigen. Hybridoma Hybridomics. 2002;21(1):81–82.
   Google Scholar
• Yücel F, Manav Aİ, Başalp A. Production and characterization of monoclonal antibodies against hepatitis B viruses and application of a quick sandwich ELISA. Hybrid Hybridomics. 2003;22:173–177.
   PubMedGoogle Scholar
• Bajrovic K, Erdag B, Atalay OE, et al. Full resistance to tobacco mosaic virus infection conferred by the transgenic expression of a recombinant antibody in tobacco. Biotechnol Biotechnol Equip. 2001;15(1):21–27.
   Web of Science ®Google Scholar
• Erdag B, Balcioglu BK, Ozdemir Bahadir A, et al. Identification of novel neutralizing single-chain antibodies against vascular endothelial growth factor receptor 2. Biotechnol Appl Biochem. 2011;58(6):412–422.
   PubMed Web of Science ®Google Scholar
• Bahadir AO, Balcioglu BK, Uzyol KS et al. Phage displayed HBV core antigen with immunogenic activity. Appl Biochem Biotechnol. 2011;165:1437–1447.
   PubMed Web of Science ®Google Scholar
• Atalay EÖ, Erdag B, Çırakoglu B. The use of Polypeptide Probes selected from Artificial Peptide libraries for the recognation and differentiation of DNA sequences. Tr J Med Sci. 1999;29:349–354.
   Google Scholar
• Ruiz M, Lefranc MP. IMGT gene identification and Colliers de Perles of human immunoglobulins with known 3D structures. Immunogenetics. 2002;53:857–883.
   PubMed Web of Science ®Google Scholar
• Kaas Q, Ehrenmann F. Lefranc MP, IG, TR and IgSF, MHC and MhcSF: what do we learn from the IMGT Colliers de Perles? Brief Funct Genomic Proteomic. 2007;6:253–264.
   PubMedGoogle Scholar
• Ehrenmann F, Giudicelli V, Duroux P, et al. IMGT/Collier de Perles: IMGT standardized representation of domains (IG, TR, and IgSF variable and constant domains, MH and MhSF groove domains). Cold Spring Harbor Protoc. 2011;6:726–736.
   Google Scholar
• Kala M, Bajaj K, Sinha S. Direct antigen capture by soluble scFv antibodies. A method for detection, characterization, and determination of affinity. Appl Biochem Biotechnol. 2001;90(1):11–22.
   PubMed Web of Science ®Google Scholar
• Balcioglu BK. Ozdemir-Bahadir A, Hinc D, et al. Cost effective filamentous phage based immunization nanoparticles displaying a full-length hepatitis B virus surface antigen, Adv Biosci Biotechnol. 2014;05:46–53.
   Google Scholar
• Kacar T, Zin MT, So C, et al. Directed self-immobilization of alkaline phosphatase on micro-patterned substrates via genetically fused metal-binding peptide. Biotechnol Bioeng. 2009;103(4):696–705.
   PubMed Web of Science ®Google Scholar
• Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: a laboratory manual. 2nd ed. New York (NY): Cold Spring Harbor Laboratory Press; 1989, p. 1659.
   Google Scholar
• Lindner P, Bauer K, Krebber A, et al. Specific detection of his-tagged proteins with recombinant anti-His tag scFv-phosphatase or scFv-phage fusions. Bio. Techniques. 1997;22:140–149.
   PubMed Web of Science ®Google Scholar
• Sánchez L, Ayala M, Freyre F, et al. High cytoplasmic expression in E. coli, purification, and in vitro refolding of a single chain Fv antibody fragment against the hepatitis B surface antigen. J Biotechnol. 1999;72:13–20.
   PubMed Web of Science ®Google Scholar
• Custer B, Sullivan SD, Hazlet TK, et al. Global epidemiology of hepatitis B virus. J Clin Gastroenterol. 2004;38:S158–S168.
   PubMed Web of Science ®Google Scholar
• Siegemund M, Richter F, Seifert O, et al. Expression and purification of recombinant antibody formats and antibody fusion proteins. Monoclonal Antibodies, Methods Mole Biol. 2014;1131:273–295.
   PubMedGoogle Scholar
• Kierny MR, Cunningham TD, Kay BK. Detection of biomarkers using recombinant antibodies coupled to nanostructured platforms. Nano Rev. 2012;3:17240 DOI:10.3402/nano.v3i0.17240.
   Google Scholar
• Xu L, Tang WH, Huang CC, et al. Systemic p53 gene therapy of cancer with immunolipoplexes targeted by anti-transferrin receptor scFv. Mol Med. 2001;7:723–734.
   PubMed Web of Science ®Google Scholar
• Boado RJ, Ji A, Pardridge WM. Cloning and expression in Pichia pastoris of a genetically engineered single chain antibody against the rat transferrin receptor. J Drug Target. 2000;8:403–412.
   PubMed Web of Science ®Google Scholar
• Rathore D, Batra JK. Construction, expression and characterization of chimaeric toxins containing the ribonucleolytic toxin restrictocin: intracellular mechanism of action. Biochem J. 1997;324(3):815–822.
   PubMed Web of Science ®Google Scholar
• Sheng X, Xiangrong R, Xing Y, et al. Purification of an anti-HBsAg scFv and measurement of its affinity constant. Chin J Pathophysiol, 2002;18(9):1069–1073.
   Google Scholar
• Tan W, Meng Y, Li H, et al. A bispecific antibody against two different epitopes on hepatitis B surface antigen has potent hepatitis B virus neutralizing activity. 2013;5:946–955.
   Google Scholar
• Shin YW, Ryoo, KW Hong, et al. Human monoclonal antibody against Hepatitis B virus surface antigen (HBsAg). Antiviral Res. 2007:75;113–120.
   PubMed Web of Science ®Google Scholar
• Seo HD, Lee J, Kim YJ, et al. Alkaline phosphatase-fused repebody as a new format of immuno-reagent for an immunoassay. Analytica Chimica Acta. 2017;950:184–191.
   PubMed Web of Science ®Google Scholar
• Gu X, Jia X, Feng J, et al. Molecular modeling and affinity determination of scFv antibody: proper linker peptide enhances its activity. Ann Biomed Eng. 2010;38(2):537–554
   PubMed Web of Science ®Google Scholar
• Hoogenboom HR, Griffiths AD, Johnson KS, et al. Multi-subunit proteins on the surface of filamentous phage: methodologies for displaying antibody (Fab) heavy and light chains. Nucl Acids Res. 1991;19:4133–4137.
   PubMed Web of Science ®Google Scholar
• Mahoney FJ. Update on diagnosis, management, and prevention of hepatitis B virus infection. Clin Microbiol Rev. 1999;12:351–366.
   PubMed Web of Science ®Google Scholar
• Trépo C, Chan HL, Lok A. Hepatitis B virus infection. The Lancet. 2014;384(9959):2053–2063.
   PubMed Web of Science ®Google Scholar
• Pérez D, Martínez-Flores JA, Serrano M, et al. Evaluation of three fully automated immunoassay systems for detection of IgA anti-beta 2-glycoprotein I antibodies. Int Jnl Lab Hem. 2016 Oct;38(5):560–568.
   PubMed Web of Science ®Google Scholar
• Avrameas S, Ternynck T, Guesdon JL. Coupling of enzymes to antibodies and antigens. Scand J Immunol. 1978;8(7):7–20.
   Google Scholar
• Yücel F, Manav AI, Başalp A. Production and characterization of monoclonal antibodies against hepatitis B viruses and application of a quick sandwich ELISA. Hybridoma Hybridomics. 2003;22(3):173–177.
   PubMedGoogle Scholar
• Tanf DF, Zhu HF, Wang ZH, et al. Construction of single chain Fv antibody against transferrin receptor and its protein fusion with alkaline phosphatase. World J Gastroenterol. 2005 Jun 7;11(21):3300–3303.
   PubMed Web of Science ®Google Scholar
• Rau D, Kramer K, HockJ B. Single-chain Fv antibody-alkaline phosphatase fusion proteins produced by one-step cloning as rapid detection tools for ELISA. J Immunoassay Immunochemistry. 2002;23(2):129–143.
   PubMed Web of Science ®Google Scholar